D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
RPTX holding history
Repare Therapeutics Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RPTX overviewAll 13F holders of RPTXFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −149,748−100.0% | Sold out | Holders |
| Q3 2024 | 149,748 | $515.1K | <0.1% | +174+0.1% | Added | Holders |
| Q2 2024 | 149,574 | $493.6K | <0.1% | +29,441+24.5% | Added | Holders |
| Q1 2024 | 120,133 | $565.8K | <0.1% | +42,954+55.7% | Added | Holders |
| Q4 2023 | 77,179 | $563.4K | <0.1% | +77,179 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −11,895−100.0% | Sold out | Holders |
| Q2 2023 | 11,895 | $125.8K | <0.1% | −31,858−72.8% | Reduced | Holders |
| Q1 2023 | 43,753 | $430.5K | <0.1% | −63,521−59.2% | Reduced | Holders |
| Q4 2022 | 107,274 | $1.58M | <0.1% | +41,890+64.1% | Added | Holders |
| Q3 2022 | 65,384 | $793.0K | <0.1% | −8,857−11.9% | Reduced | Holders |
| Q2 2022 | 74,241 | $1.04M | <0.1% | +74,241 | New | Holders |